GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Everest Medicines Ltd (HKSE:01952) » Definitions » Machinery, Furniture, Equipment

Everest Medicines (HKSE:01952) Machinery, Furniture, Equipment : HK$189.6 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Everest Medicines Machinery, Furniture, Equipment?

Everest Medicines's Machinery, Furniture, Equipment for the quarter that ended in Jun. 2024 was HK$189.6 Mil.

Everest Medicines's quarterly Machinery, Furniture, Equipment declined from Jun. 2023 (HK$147.5 Mil) to Dec. 2023 (HK$98.6 Mil) but then increased from Dec. 2023 (HK$98.6 Mil) to Jun. 2024 (HK$189.6 Mil).

Everest Medicines's annual Machinery, Furniture, Equipment increased from Dec. 2021 (HK$7.0 Mil) to Dec. 2022 (HK$33.5 Mil) and increased from Dec. 2022 (HK$33.5 Mil) to Dec. 2023 (HK$98.6 Mil).


Everest Medicines Machinery, Furniture, Equipment Historical Data

The historical data trend for Everest Medicines's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Everest Medicines Machinery, Furniture, Equipment Chart

Everest Medicines Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment
Get a 7-Day Free Trial 1.88 1.95 7.01 33.48 98.62

Everest Medicines Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 9.60 33.48 147.55 98.62 189.56

Everest Medicines Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Everest Medicines Business Description

Traded in Other Exchanges
Address
1168 West Nanjing Road, 16th Floor, CITIC Pacific Plaza, Jing’an District, Shanghai, CHN, 200041
Everest Medicines Ltd is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of potentially novel or differentiated therapies and vaccines to address critical unmet medical needs initially in the Asia Pacific markets and eventually around the world. Its product pipeline includes; Nefecon (TarpeyoTM), EVER001 (previously known as XNW1011), PTX-COVID19-B, Eravacycline (Xerava), EVER206 (also known as SPR206), and others.
Executives
Fu Wei 2307 Founder of a discretionary trust who can infl
Nova Aqua Limited 2201 Interest of corporation controlled by you
C-bridge Joint Value Creation Limited 2201 Interest of corporation controlled by you
Everest Management Holding Co., Ltd. 2101 Beneficial owner
Ra Capital Management, L.p. 2102 Investment manager
Kolchinsky Peter 2305 Beneficiary of a trust
Kolchinsky Anna Inge Leonore Haas 2202 Interest of your spouse
Ra Capital Healthcare Fund, L.p. 2101 Beneficial owner
Ra Capital Healthcare Fund Gp, Llc 2201 Interest of corporation controlled by you
Fu Wei 2307 Founder of a discretionary trust who can infl
Janchor Partners Limited 2102 Investment manager
C-bridge Capital Gp, Ltd. 2501 Other
Vistra Trust (singapore) Pte. Limited 2501 Other
C-bridge Capital Gp Iv, Ltd. 2201 Interest of corporation controlled by you
C-bridge Iv Investment Nine Limited 2101 Beneficial owner

Everest Medicines Headlines

No Headlines